Table 1.
Reference | Study Design | Results | Limitations |
---|---|---|---|
Pillai SG, et al. (2009)59 | GWAS of COPD in 1,633 participants in a case-control study in Norway, with subsequent replication of top results in additional cohorts (ICGN, NETT-NAS, and BEOCOPD) |
|
|
Cho MH, et al. (2010)63 | GWAS of COPD in 4,320 subjects in three case-control studies: Norway, NETT-NAS, and ECLIPSE. Replication was attempted in the COPDGene, BEOCOPD and ICGN studies. | A SNP in FAM13A, rs7671167, was significantly associated with COPD in the discovery cohort and in two of three replication cohorts (combined P=1.2 × 10−11, combined odds ratio for case-control studies 0.76, 95% confidence interval 0.69–0.83). |
|
Kong X, et al. (2011)65 | GWAS of percent emphysema detected by computed tomography (CT) in the Norway, ECLIPSE, and NETT studies. |
|
|
Wan E, et al. (2011)72 | GWAS of body mass index (BMI) in ~3,000 subjects with COPD in three cohorts: ECLIPSE, Norway, and NETT, with replication attempted in 502 subjects in COPDGene. A GWAS of fat-free mass index (FFMI) in COPD subjects was conducted in ECLIPSE and Norway | SNP rs8050136, located in the intron of the fat mass and obesity–associated gene (FTO) was significantly associated with BMI P=4.97 × 10−7) and FFMI (p = 1.19 × 10−7) in the discovery cohort. Findings for BMI were replicated in COPDGene (P=6 × 10−3). |
|
SNP = single nucleotide polymorphism
ICGN = International COPD Genetics Network
NETT = National Emphysema Treatment Trial
NAS = Normative Aging Study
BEOCOPD = Boston Early-Onset COPD
Genetic Epidemiology of COPD: COPDGene Study
HRCT = high resolution computed tomography of the thorax